Reviewing the role and efficacy of ruxolitinib in myelofibrosis ten years after its approval VJHemOnc – Video Journal of Hematology & HemOnc 1:15 1 year ago 257 Далее Скачать
Real-world use of ruxolitinib in patients with myelofibrosis with anemia or thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 2:07 1 year ago 419 Далее Скачать
Ruxolitinib combinations in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:14 1 year ago 150 Далее Скачать
The Role of Ruxolitinib in Myeloproliferative Neoplasms Targeted Oncology 1:05 4 years ago 114 Далее Скачать
Phase II study update of navtemadlin in patients with myelofibrosis R/R to ruxolitinib VJHemOnc – Video Journal of Hematology & HemOnc 3:44 1 year ago 239 Далее Скачать
Ruxolitinib, pacritinib, fedratinib or momelotinib for thrombocytopenic patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:05 2 years ago 632 Далее Скачать
The efficacy of ruxolitinib re-treatment in patients with MF VJHemOnc – Video Journal of Hematology & HemOnc 1:41 2 years ago 130 Далее Скачать
Ongoing clinical trials of ruxolitinib-based combinations in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 5:12 2 years ago 135 Далее Скачать
Pelabresib in myelofibrosis: the MANIFEST trials VJHemOnc – Video Journal of Hematology & HemOnc 1:34 1 year ago 340 Далее Скачать
Dr. Harrison on 5-Year Follow-Up Data on Ruxolitinib in Patients With Myelofibrosis OncLive 2:30 8 years ago 367 Далее Скачать
The characteristics of patients with myelofibrosis taking ruxolitinib for 3 or more years VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 years ago 653 Далее Скачать
Phase I/II Study Evaluates Zilurgisertib Plus or Minus Ruxolitinib in Myelofibrosis Blood Cancers Today 5:50 1 year ago 80 Далее Скачать
REFINE: Phase II study of navitoclax + ruxolitinib in JAK inhibitor-naive patients with MF VJHemOnc – Video Journal of Hematology & HemOnc 2:12 2 years ago 251 Далее Скачать
Navtemadlin and its role in the treatment of R/R myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:12 2 years ago 102 Далее Скачать
An update on MANIFEST: pelabresib monotherapy or as add-on to ruxolitinib in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:56 1 year ago 300 Далее Скачать
Pacritinib versus ruxolitinib in patients with myelofibrosis and thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 1:59 2 years ago 330 Далее Скачать
Therapies for patients who progress on JAK inhibitors: imetelstat, navtemadlin, selinexor & TP-3654 VJHemOnc – Video Journal of Hematology & HemOnc 3:13 1 year ago 174 Далее Скачать
Fedratinib Compared to Ruxolitinib in the Frontline Setting for Treatment of Myelofibrosis Targeted Oncology 1:40 5 years ago 340 Далее Скачать
